Drug Profile
Ethinylestradiol/levonorgestrel monophasic - Bayer Schering Pharma
Alternative Names: Levlite; Levonorgestrel/ethinylestradiol - Berlex; Microgynon 20; Microgynon 30; Microgynon Suave; Microlevlen ED; Microlite; MiranovaLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 11 Feb 2015 Launched for Contraception/Pregnancy (Prevention) in United Kingdom, Austria, Belgium, Greece, Israel, Netherlands, Poland, Singapore, Finland, Czech Republic, Russia, Spain, Norway, Thailand, Indonesia, Chile, Mexico, Malaysia and Hong Kong (PO) prior to February 2015
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)